Skip to main content
. 2023 Dec 11;16:6023–6038. doi: 10.2147/JIR.S440722

Table 2.

Baseline Characteristics of the Patients Stratified by the Different AF Types

Parameters Nonparoxysmal Atrial Fibrillation P value Paroxysmal Atrial Fibrillation P value
Total n=336 Recurrence (+) n =114 Recurrence (-) n =222 Total n=302 Recurrence (+) n =61 Recurrence (-) n =241
Demographics
 Age 65.7±9.9 64.7±9.9 66.2±9.8 0.196 65.9±11.2 69.4±10.8 64.9±11.1 0.006
 Female sex 166 (49.4) 64 (56.1) 102 (45.9) 0.077 166 (55.0) 45 (73.8) 121 (50.2) 0.001
 BMI 25.1±3.2 25.6±3.6 24.8±3.0 0.051 24.5±3.2 24.0±2.9 24.6±3.3 0.160
 Current Smoking 63 (18.8) 16 (14.0) 47 (21.2) 0.113 38 (12.6) 6 (9.8) 32 (13.3) 0.469
Previous medical history
 AF duration 12 (3, 60) 36 (6, 84) 12 (3, 36) 0.001 12 (4, 48) 24 (7, 48) 12 (4, 48) 0.439
 Hypertension 181 (53.9) 58 (50.9) 123 (55.4) 0.430 168 (55.6) 36 (59.0) 132 (54.8) 0.551
 Diabetes mellitus 71 (21.1) 23 (20.2) 48 (21.6) 0.759 63 (20.9) 15 (24.6) 48 (19.9) 0.442
 CHD 32 (9.5) 7 (6.1) 25 (11.3) 0.130 39 (12.9) 10 (16.4) 29 (12.0) 0.364
 CHF 110 (32.7) 39 (34.2) 71 (32.0) 0.680 22 (7.3) 6 (9.8) 16 (6.6) 0.409
 Previous stroke 20 (6.0) 9 (7.9) 11 (5.0) 0.281 14 (4.6) 6 (9.8) 8 (3.3) 0.042
 PAD 13 (3.9) 5 (4.4) 8 (3.6) 0.769 10 (3.3) 6 (9.8) 4 (1.7) 0.006
 COPD 15 (4.5) 3 (2.6) 12 (5.4) 0.244 13 (4.3) 3 (4.9) 10 (4.1) 0.730
Laboratory data
 SBP 125±17 125±18 125±17 0.989 128±17 129±19 127±17 0.523
 HR 78±18 77±15 79±19 0.490 75±20 83±26 74±17 0.042
 FBG 5.5±1.3 5.6±1.5 5.5±1.1 0.771 5.5±1.4 5.5±1.2 5.5±1.4 0.852
 Homocysteine 14.9±8.9 14.5±6.9 15.0±9.8 0.627 12.6±4.7 12.1±3.8 12.7±4.9 0.407
 BNP 192 (102, 349) 176 (94, 339) 203 (108, 367) 0.575 71 (39, 170) 119 (68, 238) 64 (34, 167) 0.004
 eGFR 84.0±19.0 80.5±20.0 85.8±18.2 0.015 85.9±20.4 77.9±20.2 87.9±20.0 0.001
 Alb 39.7±4.2 39.8±3.8 39.6±4.4 0.816 40.1±3.7 39.8±3.6 40.2±3.7 0.523
 BUA, umol/L 382±105 375±99 386±109 0.357 352±97 354±109 352±95 0.871
 Cholesterol 4.13±1.05 4.08±0.91 4.15±1.12 0.597 4.24±1.05 4.12±1.01 4.27±1.06 0.339
 Triglyceride 1.39±0.75 1.43±0.67 1.37±0.79 0.518 1.53±1.08 1.60±1.18 1.52±1.06 0.634
 Platelet 153±57 157±49 151±60 0.366 165±52 170±56 164±51 0.458
 Lymphocyte 1.66±0.64 1.51±0.64 1.73±0.63 0.002 1.74±0.55 1.67±0.62 1.76±0.53 0.249
Imaging
 LAD 44.4±4.8 45.7±4.4 43.6±4.9 <0.001 40.0±4.5 41.0±5.1 38.4±4.2 <0.001
 LVEDd 46.8±5.5 46.1±4.9 47.1±5.7 0.114 45.1±3.9 44.6±3.2 45.2±4.1 0.394
 LVEF 57.4±6.9 57.6±5.9 57.2±7.4 0.643 60.7±3.8 60.9±3.2 60.7±3.9 0.684
Discharge medicine
 Anticoagulant drugs 322 (95.8) 110 (96.5) 212 (95.5) 0.779 302 (100.0) 61 (100.0) 241 (100.0) 1.000
 Antiarrhythmic drugs 295 (87.8) 98 (86.0) 197 (88.7) 0.462 260 (86.1) 46 (75.4) 214 (88.8) 0.007
Complications 38 (11.3) 15 (13.2) 23 (10.4) 0.443 15 (5.0) 3 (4.9) 12 (5.0) 1.000
PLR 104±49 120±56 95±43 <0.001 104±55 120±93 100±39 0.109
CHA2DS2‑VASc score 2.51±1.52 2.54±1.61 2.50±1.47 0.802 2.37±1.59 3.10±1.81 2.18±1.48 <0.001
APPLE score 2.31±0.84 2.38±0.90 2.27±0.81 0.809 0.82±0.77 1.36±0.88 0.69±0.68 <0.001

Note: Data are presented as the mean ± SD, median (IQR), or n (%).

Abbreviations: AF, atrial fibrillation; BMI, body mass index; CHD, coronary heart disease; CHF, chronic heart failure; PAD, peripheral artery disease; COPD, chronic obstructive pulmonary disease; SBP, systolic blood pressure; HR, heart rate; FBG, fasting blood-glucose; BNP, brain natriuretic peptide; eGFR, Estimated glomerular filtration rate; BUA, blood uric acid; Alb, albumin; LAD, left atrial diameter; LVED, left ventricular end diastolic diameter; LVEF, left ventricular ejection fraction; PLR, platelet to lymphocyte rateo.